Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-306
Closed -$1K 4916
2022
Q2
$1K Sell
306
-15
-5% -$54 ﹤0.01% 4937
2022
Q1
$1K Buy
+321
New +$1.31K ﹤0.01% 4836
2021
Q4
Sell
-2
Closed 4367
2021
Q3
$0 Sell
2
-17
-89% -$65 ﹤0.01% 4841
2021
Q2
$0 Hold
19
﹤0.01% 4943
2021
Q1
$0 Sell
19
-100
-84% -$515 ﹤0.01% 4886
2020
Q4
$1K Hold
119
﹤0.01% 4825
2020
Q3
$1K Hold
119
﹤0.01% 5142
2020
Q2
$1K Sell
119
-518
-81% -$6.07K ﹤0.01% 5472
2020
Q1
$9K Buy
+637
New +$10.8K ﹤0.01% 5842

Other funds holding GNFT

Barclays's GNFT Position: Q3 2022 in Review

Barclays sold out of Genfit (GNFT) in Q3 2022, closing a stake of 306 shares — an estimated $1K sold.

Barclays first reported a position in GNFT in Q1 2020 and held it in 9 quarters. The position peaked at $9K in Q1 2020. 17 funds tracked by Wall St. Rank hold GNFT as of Q3 2022.

  • Barclays reported no remaining Genfit position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 306 Genfit shares in Q3 2022, an estimated $1K.
  • Barclays first reported a position in Genfit in Q1 2020 and held it in 9 quarters.
  • Barclays's Genfit position peaked at $9K in Q1 2020.
  • 17 funds tracked by Wall St. Rank held Genfit as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.